TKNO logo

TKNO Alpha Teknova, Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$7.25
+0.44 (+6.43%)

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompas…

Market Cap: $388.57Mwww.teknova.com

Price

No data yet.

Social Signal Score

70
5d
70
1 mentions
30d
70
1 mentions
60d
70
1 mentions
90d
70
1 mentions
news: 1

Revenue

$12.19M+29.74%
$7.87M$9.31M$10.75M$12.19M
Sep 2021Jun 2026

Analyst Estimates

FY2025
$-0.33
$-0.33$-0.32
3 analysts
FY2026
$-0.31
$-0.32$-0.30
2 analysts
FY2027
$-0.26
$-0.27$-0.26
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Stephen Gunstream
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
158
Beta
0.68
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
4.78
www.teknova.com